FDA Panel Votes Against Naproxen Heart Safety Claim

An FDA advisory committee said on Tuesday that available evidence does not prove that the painkiller naproxen carries a lower cardiac risk than rival products.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news